Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.
Betacoronavirus
/ pathogenicity
COVID-19
Cardiology
/ standards
Cardiovascular Agents
/ adverse effects
Cardiovascular Diseases
/ diagnosis
Consensus
Coronavirus Infections
/ diagnosis
Host-Pathogen Interactions
Humans
Pandemics
Pneumonia, Viral
/ diagnosis
Preventive Health Services
/ standards
Risk Assessment
Risk Factors
Risk Reduction Behavior
SARS-CoV-2
Cardiovascular prevention
Cardiovascular risk
Covid-19
Sars-Cov-2
Journal
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
ISSN: 1179-1985
Titre abrégé: High Blood Press Cardiovasc Prev
Pays: New Zealand
ID NLM: 9421087
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
26
06
2020
accepted:
21
07
2020
pubmed:
1
8
2020
medline:
21
10
2020
entrez:
1
8
2020
Statut:
ppublish
Résumé
In 2020, the Sars-Cov-2 pandemic is causing a huge and dramatic impact on healthcare systems worldwide. During this emergency, fragile patients suffering from other comorbidities, especially patients susceptible to or affected by cardiovascular disease, are the ones most exposed to the poorer outcomes. Therefore, it is still mandatory to continue to strictly adhere to the rules of cardiovascular prevention. This document aims to provide all doctors with simple and clear recommendations in order to spread useful messages to the widest number of subjects in order to continue the battle against cardiovascular diseases even in times of pandemic.
Identifiants
pubmed: 32734561
doi: 10.1007/s40292-020-00401-1
pii: 10.1007/s40292-020-00401-1
pmc: PMC7391228
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
373-377Références
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):81-82
pubmed: 30506512
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924
pubmed: 32573903
High Blood Press Cardiovasc Prev. 2017 Jun;24(2):149-155
pubmed: 28168358
Aging (Albany NY). 2020 Jun 23;12(12):12410-12421
pubmed: 32575078
Curr Pharm Des. 2014;20(22):3579-94
pubmed: 24180381
Heart. 2020 Aug;106(15):1119-1121
pubmed: 32451360
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1409-1417
pubmed: 32571612
Heart Lung Circ. 2020 Jul;29(7):e99-e104
pubmed: 32473781
Eur J Heart Fail. 2011 Apr;13(4):347-57
pubmed: 21436360
Curr Opin Cardiol. 2020 Jul;35(4):428-433
pubmed: 32398607
BMJ. 2019 Oct 21;367:l5310
pubmed: 31636059
Mater Sociomed. 2020 Mar;32(1):71-76
pubmed: 32410896
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):105-108
pubmed: 32266708
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):248-251
pubmed: 32286607
G Ital Cardiol (Rome). 2014 Oct;15(10 Suppl 1):3S-10S
pubmed: 25426833
BMJ Open. 2013 Nov 20;3(11):e003813
pubmed: 24259391
Eur J Cardiovasc Nurs. 2020 Aug;19(6):486-494
pubmed: 32380858
Hypertension. 2020 Aug;76(2):366-372
pubmed: 32564693
High Blood Press Cardiovasc Prev. 2018 Sep;25(3):327-341
pubmed: 30232768
Int J Environ Res Public Health. 2020 Jun 21;17(12):
pubmed: 32575825
J Am Heart Assoc. 2020 Jul 7;9(13):e016997
pubmed: 32418463
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):187-96
pubmed: 27072129
BMJ. 2015 Feb 05;350:h158
pubmed: 25655523
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
J Cardiovasc Med (Hagerstown). 2019 Oct;20(10):631-639
pubmed: 31436678
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131